Bibliography
- Hobby GL, Dawson MH, Meyer K, The relationship between spreading factor and hyaluronidase. J Exp Med 1941;73:109-23
- Bookbinder LH, Hofer A, Haller MF, A recombinant human enzyme for enhanced interstitial transport of therapeutics. J Control Release 2006;114:230-41
- Williams RG. The effects of continuous local injection of hyaluronidase on skin and subcutaneous tissue in rats. Anat Rec 1955;122:349-61
- Pillwein K, Fuiko R, Slavc I, Hyaluronidase additional to standard chemotherapy improves outcome for children with malignant brain tumors. Cancer Lett 1998;131:101-8
- Eberhart AH, Weiler CR, Erie JC. Angioedema related to the use of hyaluronidase in cataract surgery. Am J Ophthalmol 2004;138:142-3
- Yocum RC, Kennard D, Heiner LS. Assessment and implication of the allergic sensitivity to a single dose of recombinant human hyaluronidase injection: a double- blind, placebo-controlled clinical trial. J Infus Nurs 2007;30:293-9
- Evered D, Whelan J. The biology of hyaluronan. New York: Wiley; 1988
- Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6:2397-404
- FDA Docket No. 2003P-0494/CP1. Department of Health & Human Services. Rockville, MD, 2004. Available from: http://www.fda.gov/ohrms/dockets/dockets/05p0134/05p-0134-cp00001-Tab-C-vol1.pdf [Last accessed 18 November 2009]
- Hyaluronidase (2008). (Bovine, Amphadase™ Hydase™) (Ovine, Vitrase™) (Human Recombinant, Hylenex). National PBM Drug Monograph. VHA Pharmacy Benefits Management Service and the Medical Advisory Panel. Washington, DC. Available from: http://www.pbm.va.gov/Clinical%20Guidance/Drug%20Monographs/Hyaluronidase%20Monograph%20(Amphadase,%20Hydase,%20Vitrase,%20Hylenex)%20Final.doc [Last accessed 18 November 2009]
- Menzel EJ, Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett 1998;131:3-11
- Frost G. Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration. Expert Opin Drug Deliv 2007;4:427-40
- Racz GB, Heavner JE, Trescot A. Percutaneous lysis of epidural adhesions – evidence for safety and efficacy. Pain Pract 2008;8:277-86
- Johnsson C, Hallgren R, Elvin A, Hyaluronidase ameliorates rejection-induced edema. Transpl Int 1999;12:235-43
- Keshavan H, Venkatesh DNB, Umamaheswara R. Treatment of supraglottic airway edema by local hyaluronidase. Anesthesiology 2007;106:1254-5
- DeVries CR, Miller AK, Packer MG. Reduction of paraphimosis with hyaluronidase. Urology 1996;48:464-5
- McGuire B, Brannigan AE, O'Connell PR. Hyaluronidase assisted reduction of intestinal intussusception: a novel application. Ir Med J 2005;98:146-7
- Girish KS, Kemparaju K. The magic glue and its eraser hyaluronidase: a biological overview. Life Sci 2007;80:1921-43
- Nathalie N, Mohamed B, Hayat L, The role of hyaluronidase on lidocaine and bupivicaine pharmacokinetics after peribulbar blockade. Reg Anesth Pain Med 1996;82:1060-4
- Kallio H, Paloheimo M, Maunukseka E. Hyaluronidase as an adjuvant in bupivacaine-lidocaine mixture for retrobulbar/peribulbar block. Anesth Analg 2000;91:934-7
- Schulze C, Bittorf T, Walzel H, Experimental evaluation of hyaluronidase activity in combination with specific drugs applied in clinical techniques of interventional pain management and local anesthesia. Pain Physician 2008;11:877-83